Table 1. Altered mutations/CNVs stratified for therapy administered.
Number of mutations | Number of altered mutations | Number of CNVs | Number of altered CNVs | Overall detected | Overall altered | |
---|---|---|---|---|---|---|
RCTX | 20 | 3 (15%) | 7 | 0 (0%) | 27 | 3 (11%) |
CTX | 48 | 11 (23%) | 26 | 6 (23%) | 74 | 17 (23%) |
Cis/Vino | 21 | 2 (10%) | 4 | 0 (0%) | 25 | 2 (8%) |
Cis/Pem | 7 | 4 (57%) | 2 | 2 (100%) | 9 | 6 (67%) |
Cis/Tax | 14 | 0 (0%) | 9 | 0 (0%) | 23 | 0 (0%) |
Cis/Gem | 26 | 8 (31%) | 18 | 4 (22%) | 44 | 12 (27%) |